Bulk MSM Powder
Spider Bite Research
MSM Patents
CalmCream
James Coburn
MSM Research
Price Competition  Finnish MSM report

Vibrant Life Products

Family Of Three Chelation Formulas
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials

Ayurvedic Herbal MSM

Bulk MSM Web

Shopping Cart

Separate Search Page or
 

Separate Search Page
or search below

Loading
Navigation Help

CalmCream Slide Show

Ingredients
Technical
Write To Karl Loren Table Of Contents

TMG

TriMethylGlycine


MedLine

Search Results

Results for your query:
Search all fields for: TriMethylGlycine
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans
Documents: 1 to 5 of 5

1

Top Of Menu

Lundberg P, et al; 1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia. (Clin Chem, 1995 Feb, Abstract available) [MEDLINE]

2 Le Rudulier D, et al; Osmoregulation in Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under stress by proline betaine, gamma-butyrobetaine, and other related compounds. (Can J Microbiol, 1984 Mar, Abstract available) [MEDLINE]
3 Söderling E, et al; Betaine-containing toothpaste relieves subjective symptoms of dry mouth. (Acta Odontol Scand, 1998 Apr, Abstract available) [MEDLINE]
4 Wang JA, et al; Betaine:homocysteine methyltransferase--a new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes. (Clin Chim Acta, 1991 Dec, Abstract available) [MEDLINE]
5 Wilcken DE, et al; Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients. (Metabolism, 1985 Dec, Abstract available) [MEDLINE]

  NLM database Documents

Record 1 from database: MEDLINE
Return To Top

Title
1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia.
Author
Lundberg P; Dudman NP; Kuchel PW; Wilcken DE
Address
Department of Biochemistry, University of Sydney, NSW, Australia.
Source
Clin Chem, 1995 Feb, 41:2, 275-83
Abstract
Urinary N,N,N-trimethylglycine (betaine) and N,N-dimethylglycine (DMG) have been identified and quantified for clinical purposes by proton nuclear magnetic resonance (1H NMR) measurement in previous studies. We have assessed these procedures by using both one-dimensional (1-D) and 2-D NMR spectroscopy, together with pH titration of urinary extracts to help assign 1H NMR spectral peaks. The betaine calibration curve linearity was excellent (r = 0.997, P = 0.0001) over the concentration range 0.2-1.2 mmol/L, and CVs for replicate betaine analyses ranged from 7% (n = 10) at the lowest concentration to 1% (n = 9) at the highest. The detection limit for betaine was < 15 mumol/L. Urinary DMG concentrations were substantially lower than those of betaine. Urinary betaine and DMG concentrations measured by 1H NMR spectroscopy from 13 patients with premature vascular disease and 17 normal controls provided clinically pertinent data. We conclude that 1H NMR provides unique advantages as a research tool for determination of urinary betaine and DMG concentrations.
Language of Publication
English
Unique Identifier
95179851

Return To Top


MeSH Heading (Major)
Betaine|*UR; Homocysteine|*BL; Nuclear Magnetic Resonance|*; Vascular Diseases|*UR
MeSH Heading
Adult; Amino Acid Metabolism, Inborn Errors|UR; Creatinine|UR; Glycine|UR; Human; Hydrogen-Ion Concentration; Male; Regression Analysis; Sarcosine|AA/UR; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0009-9147
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Osmoregulation in Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under stress by proline betaine, gamma-butyrobetaine, and other related compounds.
Author
Le Rudulier D; Bernard T; Goas G; Hamelin J
Address
 
Source
Can J Microbiol, 1984 Mar, 30:3, 299-305
Abstract
Exogenous proline betaine ( stachydrine or N- dimethylproline ) or gamma-butyrobetaine (gamma-trimethylaminobutyrate), at a concentration as low as 1 mM, were found to stimulate the growth rate of Klebsiella pneumoniae, wild type M5A1 , in media of inhibitory osmotic strength (0.8 M NaC1). Simultaneously, nitrogen fixation by whole cells, a process particularly sensitive to osmotic stress, was strongly enhanced by these compounds. However, in the absence of sodium chloride, both the growth and nitrogen fixation were not affected by the addition of the methylammonium derivatives in the medium. The sensitivity of the nitrogen fixation to osmotic stress was used as a bioassay to evaluate the potentiality of osmoprotective compound in relation to the number of methyl groups on the nitrogen atom of glycine, proline, and gamma-aminobutyrate. Experiments with sarcosine ( monomethylglycine ), dimethylglycine, and glycine betaine ( trimethylglycine ), or experiments with mono- and di- methylproline or gamma-mono-, gamma-di, gamma-tri- methylaminobutyrate , indicated that the greatest stress tolerance was always obtained with the more N-methylated compounds.
Language of Publication
English
Unique Identifier
84205133

Return To Top


MeSH Heading (Major)
Betaine|*AA/PD; Klebsiella pneumoniae|*DE/GD/ME; Proline|*AA/PD; Water-Electrolyte Balance|*DE
MeSH Heading
Anaerobiosis; Human; Nitrogen Fixation|DE; Nitrogenase|ME; Osmolar Concentration; Stimulation, Chemical; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0008-4166
Country of Publication
CANADA

Record 3 from database: MEDLINE
Return To Top

Title
Betaine-containing toothpaste relieves subjective symptoms of dry mouth.
Author
Söderling E; Le Bell A; Kirstilä V; Tenovuo J
Address
Institute of Dentistry, University of Turku, Finland.
Source
Acta Odontol Scand, 1998 Apr, 56:2, 65-9
Abstract
Subjects with dry mouth often experience irritation of the oral mucosa when using sodium lauryl sulfate containing products for oral hygiene. Betaine, or trimethylglycine, reduces skin-irritating effects of ingredients of cosmetics such as sodium lauryl sulfate. The aim of the present study was to compare the effects of a betaine-containing toothpaste with a regular toothpaste on the oral microbial flora, the condition of the oral mucosa, and subjective symptoms of dry mouth in subjects with chronic dry mouth symptoms. Thirteen subjects with chronic dry mouth symptoms and with a paraffin-stimulated salivary flow rate < or = 1 mL/min participated in the double-blind crossover study. Ten subjects had a very low salivary flow rate (< or = 0.6 mL/min). The subjects used both experimental toothpastes (with or without 4% betaine) twice a day for 2 weeks. Oral examinations and microbiologic sample collections were made at the base lines preceding the two experimental periods and at the end. Standardized questions on subjective symptoms of dry mouth were used when the subjects were interviewed at the end of the two experimental periods. No study-induced significant changes were observed in the microbiologic variables (plaque index, mutans streptococci, lactobacilli, Candida species) or in the appearance of the oral mucosa. The use of the betaine-containing toothpaste was, however, associated with a significant relief of several subjective symptoms of dry mouth. Betaine appears thus to be a promising ingredient of toothpastes in general and especially of toothpastes designed for patients with dry mouth.
Language of Publication
English
Unique Identifier
98332118

Return To Top


MeSH Heading (Major)
Betaine|PD/*TU; Toothpaste|*; Wetting Agents|PD/*TU; Xerostomia|*DT
MeSH Heading
Adult; Aged; Analysis of Variance; Candida|DE; Chi-Square Distribution; Colony Count, Microbial; Cross-Over Studies; Double-Blind Method; Female; Human; Lactobacillus|DE; Male; Middle Age; Mouth Mucosa|DE; Salivation|DE; Secretory Rate|DE; Sodium Dodecyl Sulfate|AE; Streptococcus mutans|DE; Surface-Active Agents|AE; Treatment Outcome

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0001-6357
Country of Publication
NORWAY

Record 4 from database: MEDLINE
Return To Top

Title
Betaine:homocysteine methyltransferase--a new assay for the liver enzyme and its absence from human skin fibroblasts and peripheral blood lymphocytes.
Author
Wang JA; Dudman NP; Lynch J; Wilcken DE
Address
Department of Cardiovascular Medicine, Prince Henry Hospital, University of New South Wales, Sydney, Australia.
Source
Clin Chim Acta, 1991 Dec, 204:1-3, 239-49
Abstract
Chronic elevation of plasma homocysteine is associated with increased atherogenesis and thrombosis, and can be lowered by betaine (N,N,N-trimethylglycine) treatment which is thought to stimulate activity of the enzyme betaine:homocysteine methyltransferase. We have developed a new assay for this enzyme, in which the products of the enzyme-catalysed reaction between betaine and homocysteine are oxidised by performic acid before being separated and quantified by amino acid analysis. This assay confirmed that human liver contains abundant betaine:homocysteine methyltransferase (33.4 nmol/h/mg protein at 37 degrees C, pH 7.4). Chicken and lamb livers also contain the enzyme, with respective activities of 50.4 and 6.2 nmol/h/mg protein. However, phytohaemagglutinin-stimulated human peripheral blood lymphocytes and cultured human skin fibroblasts contained no detectable betaine:homocysteine methyltransferase (less than 1.4 nmol/h/mg protein), even after cells were pre-cultured in media designed to stimulate production of the enzyme. The results emphasize the importance of the liver in mediating the lowering of elevated circulating homocysteine by betaine.
Language of Publication
English
Unique Identifier
92306342

Return To Top


MeSH Heading (Major)
Fibroblasts|*EN; Liver|*EN; Lymphocytes|*EN; Methyltransferases|*AN/ME; Skin|*EN
MeSH Heading
Animal; Betaine|PD; Chickens; Homocysteine|BL/IP; Human; Methionine|IP; Sheep; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0009-8981
Country of Publication
NETHERLANDS

Record 5 from database: MEDLINE
Return To Top

Title
Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
Author
Wilcken DE; Dudman NP; Tyrrell PA
Address
 
Source
Metabolism, 1985 Dec, 34:12, 1115-21
Abstract
Homocystinuria due to cystathionine beta-synthase deficiency may be responsive to pyridoxine, a precursor of the cofactor pyridoxal phosphate, and the amount of residual enzyme activity present is the probable determinant of this. In six treated pyridoxine-responsive patients whose biochemical control of fasting plasma amino acid levels appeared optimal, we assessed the effects on plasma amino acids of standard oral methionine loads (4g/m2 of body area) before and after adding betaine (trimethylglycine) 6 g/d, to the treatment regimen of pyridoxine and folic acid. Our aim was to define the capacity of these patients to metabolize methionine and to determine whether betaine would effect a reduction in postload homocysteine levels. During the 24 hours after the methionine challenge all patients had higher plasma methionine and homocysteine and lower cysteine than did 17 normal subjects. After betaine these homocysteine responses were reduced to near normal, and there was a trend toward increased methionine. There was a direct correlation between premethionine fasting homocysteine and mean homocysteine responses during the 24 hours following the methionine load, both before (r = 0.79) and after betaine (r = 0.71). Betaine also increased plasma cysteine levels in patients with the more severe biochemical abnormalities. After betaine there were modest increases in plasma serine (mean increase 25%; P less than 0.025). Since the vascular complications of homocystinuria are related to increased plasma homocysteine, betaine therapy may reduce this risk in patients receiving a standard pyridoxine and folic acid regimen in whom there are abnormal homocysteine responses after a standard methionine load.
Language of Publication
English
Unique Identifier
86064904

Return To Top


MeSH Heading (Major)
Betaine|*TU; Cystathionine beta-Synthase|*DF; Homocystinuria|BL/*DT/ET; Hydro-Lyases|*DF; Pyridoxine|*TU
MeSH Heading
Adolescence; Adult; Child; Cysteine|BL; Drug Therapy, Combination; Female; Folic Acid|TU; Homocysteine|BL; Human; Male; Methionine|BL; Middle Age; Serine|BL; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0026-0495
Country of Publication
UNITED STATES

Return To Top

The Largest Web Presence For MSM On The Planet -- Home Page
Bulk MSM Powder MSM Capsules MSM Calm Cream
James Coburn, Oscar Winning Actor -- His Testimonial MSM Prices Personal Experiences & Testimonials
Company And Owner Background Home Page Detailed Product Information
Calm Cream Power Point Slide Show Shopping Cart General Information About MSM
MSM Research Search This Web Site Table Of Contents

Spider Bite
 Research Project

MSM Remedies Detoxification With MSM
Large Volume Wholesale Purchases Only Dosage Levels Competitive Prices and Packages
TMG Manufacturing Process DMG
Write To Karl Loren -- Click Here -- Karl Loren Promises To Answer You Personally
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.